Rabbit monoclonal Anti-MERS Spike protein (S1/RBD/MERS-RBD) IgG (Neutralizing) |
MERS122-M |
Alpha Diagnostics |
100 ul |
EUR 781.2 |
Human IgG antibody Laboratories manufactures the spike rbd sequence reagents distributed by Genprice. The Spike Rbd Sequence reagent is RUO (Research Use Only) to test human serum or cell culture lab samples. To purchase these products, for the MSDS, Data Sheet, protocol, storage conditions/temperature or for the concentration, please contact Spike RBD. Other Spike products are available in stock. Specificity: Spike Category: Rbd Group: Sequence
Sequence information
Spike S1 RBD, Fc fusion (SARS-CoV-2) |
100699-2 |
BPS Bioscience |
100 µg |
EUR 520 |
Description: SARS-CoV-2 2019-nCoV Spike protein S1 subunit, receptor binding domain (RBD), also known as SARS-CoV-2 spike RBD, novel coronavirus spike RBD and nCoV spike RBD, GenBank Accession No. QHD43416.1, a.a. 319-541, with C-terminal Fc-tag, expressed in a CHO cell expression system. MW=50 kDa. This protein runs at a higher MW by SDS-PAGE due to glycosylation. |
Erythropoietin Mimetic Peptide Sequence 20 |
H-4344.0001 |
Bachem |
1.0mg |
EUR 544.8 |
Description: Sum Formula: C72H99N17O17S2; CAS# [203397-62-0] net |
Erythropoietin Mimetic Peptide Sequence 20 |
H-4344.0005 |
Bachem |
5.0mg |
EUR 2067.6 |
Description: Sum Formula: C72H99N17O17S2; CAS# [203397-62-0] net |
Anti-Signal sequence receptor delta (2D3) |
YF-MA15624 |
Abfrontier |
100 ug |
EUR 435.6 |
Description: Mouse monoclonal to Signal sequence receptor delta |
TPA-Induced Sequence 11b (TIS11B) Antibody |
20-abx219410 |
Abbexa |
|
|
|
G-Rich Sequence Factor 1 (GRSF1) Antibody |
abx340117-100ug |
Abbexa |
100 ug |
EUR 469.2 |
|
Signal Sequence Receptor Delta (SSR4) Antibody |
20-abx137478 |
Abbexa |
-
EUR 844.80
-
EUR 393.60
-
EUR 276.00
|
|
|
Signal Sequence Receptor Alpha (SSRa) Antibody |
20-abx131611 |
Abbexa |
-
EUR 510.00
-
EUR 159.60
-
EUR 1446.00
-
EUR 693.60
-
EUR 393.60
|
- 100 ug
- 10 ug
- 1 mg
- 200 ug
- 50 ug
|
|
Neuroblastoma Amplified Sequence (NBAS) Antibody |
abx235565-100ug |
Abbexa |
100 ug |
EUR 610.8 |
|
Neuroblastoma Amplified Sequence (NBAS) Antibody |
20-abx217051 |
Abbexa |
|
|
|
Neuroblastoma Amplified Sequence (NBAS) Antibody |
20-abx321319 |
Abbexa |
|
|
|
Neuroblastoma Amplified Sequence (NBAS) Antibody |
20-abx114066 |
Abbexa |
|
|
|
Neuroblastoma Amplified Sequence (NBAS) Antibody |
20-abx003586 |
Abbexa |
-
EUR 493.20
-
EUR 710.40
-
EUR 218.40
-
EUR 376.80
|
- 100 ul
- 200 ul
- 20 ul
- 50 ul
|
|
Glioblastoma-Amplified Sequence (GBAS) Antibody |
abx146091-100ug |
Abbexa |
100 ug |
EUR 469.2 |
|
Glioblastoma-Amplified Sequence (GBAS) Antibody |
abx032970-400ul |
Abbexa |
400 ul |
EUR 627.6 |
|
Glioblastoma-Amplified Sequence (GBAS) Antibody |
abx032970-80l |
Abbexa |
80 µl |
EUR 343.2 |
|
SARS-CoV-2 (COVID-19) Spike RBD Antibody |
9087-002mg |
ProSci |
0.02 mg |
EUR 229.7 |
|
Description: Coronavirus disease 2019 (COVID-19), formerly known as 2019-nCoV acute respiratory disease, is an infectious disease caused by SARS-CoV-2, a virus closely related to the SARS virus (1). The disease is the cause of the 2019–20 coronavirus outbreak (2). The structure of 2019-nCoV consists of the following: a Spike protein (S), hemagglutinin-esterease dimer (HE), a membrane glycoprotein (M), an envelope protein (E) a nucleoclapid protein (N) and RNA. Coronavirus invades cells through Spike (S) glycoproteins, a class I fusion protein. It is the major viral surface protein that coronavirus uses to bind to the human cell surface receptor. It also mediates the fusion of host and viral cell membrane, allowing the virus to enter human cells and begin infection (3). The spike protein is the major target for neutralizing antibodies and vaccine development (4). The protein modeling suggests that there is strong interaction between Spike protein receptor-binding domain and its host receptor angiotensin-converting enzyme 2 (ACE2), which regulate both the cross-species and human-to-human transmissions of COVID-19 (5). The recent study has shown that the SARS-CoV-2 spike protein binds ACE2 with higher affinity than SARS-CoV spike protein (6). |